Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols

References

• Farowski F, Vehreschild JJ, Cornely OA. Posaconazole: a next-generation triazole antifungal. Future Microbiol 2007; 2:231–243.
   PubMed Web of Science ®Google Scholar
• Sanglard D, Coste A, Ferrari S. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 2009; 9:1029–1050.
   PubMed Web of Science ®Google Scholar
• Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999; 12:40–79.
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Denning DW. New and emerging treatments for fungal infections. J Antimicrob Chemother 2008; 61 Suppl 1:i19–i30.
   PubMed Web of Science ®Google Scholar
• Xiao L, Madison V, Chau AS, Loebenberg D, Palermo RE, McNicholas PM. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob Agents Chemother 2004; 48:568–574.
   PubMed Web of Science ®Google Scholar
• Sheng C, Zhang W, Zhang M, Song Y, Ji H, Zhu J, Yao J, Yu J, Yang S, Zhou Y, Zhu J, Lu J. Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions. J Biomol Struct Dyn 2004; 22:91–99.
   PubMed Web of Science ®Google Scholar
• Sheng C, Zhang W, Ji H, Zhang M, Song Y, Xu H, Zhu J, Miao Z, Jiang Q, Yao J, Zhou Y, Zhu J, Lü J. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking. J Med Chem 2006; 49:2512–2525.
   PubMed Web of Science ®Google Scholar
• Chen SH, Sheng CQ, Xu XH, Jiang YY, Zhang WN, He C. Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues. Biol Pharm Bull 2007; 30:1246–1253.
   PubMed Web of Science ®Google Scholar
• Sheng C, Chen S, Ji H, Dong G, Che X, Wang W, Miao Z, Yao J, Lü J, Guo W, Zhang W. Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design. J Mol Model 2010; 16:279–284.
   PubMed Web of Science ®Google Scholar
• Guillon R, Giraud F, Logé C, Le Borgne M, Picot C, Pagniez F, Le Pape P. Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols. Bioorg Med Chem Lett 2009; 19:5833–5836.
   PubMed Web of Science ®Google Scholar
• Giraud F, Logé C, Pagniez F, Crepin D, Le Pape P, Le Borgne M. Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents. Bioorg Med Chem Lett 2008; 18:1820–1824.
   PubMed Web of Science ®Google Scholar
• Pagniez F, Le Pape P. New fluorometric screening test for possible antifungal drugs. J Mycol Med 2001;11:73–78.
   Web of Science ®Google Scholar
• Tripos International. SYBYL 8.0. 1699 South Hanley Road, St. Louis, MO 63144, USA.
   Google Scholar
• Podust LM, Poulos TL, Waterman MR. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA 2001;98:3068–73.
   PubMed Web of Science ®Google Scholar
• Giraud F. PhD Thesis. Université de Nantes, Nantes Atlantique Universités, France, October 2007.
   Google Scholar
• Smith TF, Waterman MS. Identification of common molecular subsequences. J Mol Biol 1981;47:195–197.
   Web of Science ®Google Scholar
• Jones DT. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 1999; 292:195–202.
   PubMed Web of Science ®Google Scholar
• Petrey D, Xiang Z, Tang CL, Xie L, Gimpelev M, Mitros T, Soto CS, Goldsmith-Fischman S, Kernytsky A, Schlessinger A, Koh IY, Alexov E, Honig B. Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling. Proteins 2003; 53 Suppl 6:430–435.
   PubMed Web of Science ®Google Scholar
• Lüthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature 1992; 356:83–85.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK—a program to check the stereochemical quality of protein structures. J App Cryst 1993;26:283–91. http://www.ebi.ac.uk/thornton-srv/software/PROCHECK/
   Web of Science ®Google Scholar
• Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997; 267:727–748.
   PubMed Web of Science ®Google Scholar
• Marchi I, Rebelo AR, Rosa AFF, Maiochi RA. Synthesis and evaluation of the plant growth regulator property of indolic compounds derived from safrole. Quim Nova 2007;30:763–67.
   Web of Science ®Google Scholar
• Davies JR, Kane PD, Moody CJ, Slawin AM. Control of competing N-H insertion and Wolff rearrangement in dirhodium(II)-catalyzed reactions of 3-indolyl diazoketoesters. synthesis of a potential precursor to the marine 5-(3-indolyl)oxazole martefragin A. J Org Chem 2005; 70:5840–5851.
   PubMed Web of Science ®Google Scholar
• Ku JM, Jeong BS, Jew SS, Park HG. Enantioselective synthesis of (-)-cis-clavicipitic acid. J Org Chem 2007; 72:8115–8118.
   PubMed Web of Science ®Google Scholar
• Lepesheva GI, Park HW, Hargrove TY, Vanhollebeke B, Wawrzak Z, Harp JM, Sundaramoorthy M, Nes WD, Pays E, Chaudhuri M, Villalta F, Waterman MR. Crystal structures of Trypanosoma brucei sterol 14alpha-demethylase and implications for selective treatment of human infections. J Biol Chem 2010; 285:1773–1780.
   PubMed Web of Science ®Google Scholar
• Strushkevich N, Usanov SA, Park HW. Structural basis of human CYP51 inhibition by antifungal azoles. J Mol Biol 2010; 397:1067–1078.
   PubMed Web of Science ®Google Scholar